“With the approaching flu season, this new test is particularly important as SARS-CoV-2 and influenza infections can hardly be differentiated by symptoms alone,” stated Roche Diagnostics CEO Thomas Schinecker. “Now, with a single test, healthcare professionals can confidently provide the right diagnosis and most effective treatment plan for their patients.”
The test uses a single sample to differentiate between COVID-19 and the flu. Roche said the test machines can provide results for 96 tests in three hours.
Roche said it plans to deliver “as many tests as possible within the limits of supply.”
Read the full news release here.
More articles on supply chain:
NIH gives $129M to 9 companies to boost COVID-19 testing
HHS to deliver Abbott’s rapid COVID-19 tests to states this month
10 hospitals seeking supply chain talent
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
